The company basks in device orders growing at 30% sequentially and 95% y/y. Revenue will follow more slowly, but ultimately much more pronounced as the company gets 80% of revenue from supplies, not device sales, producing a flywheel effect. Enjoying 80%+ gross margin, profits, positive cash flow and no debt, it’s not too late to […]
Entries Tagged as 'ZYXI'
October 9th, 2019 · No Comments
August 5th, 2019 · Comments Off on Bull Thesis In Zynex Confirmed By Q2 Figures
The company produced stellar Q2 figures despite a rather epic sales force ramp that took S&M 111% higher in the quarter. The company can easily afford this sales ramp, and we don’t think investors appreciate the inherent flywheel effect that will come as a result. We are also getting a little more optimistic about the […]
June 10th, 2019 · Comments Off on The Zynex Party Has Much Further To Go
The medical device company sprouts SaaS-like metrics; 30%+ growth, 80% recurring revenues, 80%+ gross margin and it’s profitable and cash flow positive. The big sales force expansion depress these figures now, but will create a tremendous ratcheting up effect later. There are multiple expansion opportunities like overseas and other devices. Source: The Zynex Party Has […]